Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.45 |
| ▸ | SCN1A | P35498 | 2/20 | 0.43 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.43 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3093183 | 0.92 | CYP1A2 (0.43) | CYP1A2LMNACYP3A4MAOAADRB2 | |
| SCHEMBL3093196 | 0.86 | MAPT (0.49) | CYP1A2TSHRCYP2C19MAPTALDH1A1 | |
| SCHEMBL20210670 | 0.84 | CYP2D6 (0.54) | CYP1A2LMNAADRB2ADRB1ADRB3 | |
| SCHEMBL3096149 | 0.80 | CYP1A2 (0.42) | CYP1A2ADRB2ADRB1ADRB3CYP2C19 | |
| SCHEMBL8079309 | 0.79 | CYP1A2 (0.58) | CYP1A2LMNACYP3A4MAOAADRB2 | |
| SCHEMBL2064891 | 0.77 | CYP1A2 (0.51) | CYP1A2LMNACYP3A4MAOAADRB2 | |
| SCHEMBL6563889 | 0.77 | ALDH1A1 (0.53) | CYP3A4TSHRNPC1RAB9AMAPT | |
| SCHEMBL23486834 | 0.76 | CYP1A2 (0.58) | CYP1A2LMNACYP3A4MAOAADRB2 | |
| SCHEMBL3096170 | 0.75 | CYP1A2 (0.42) | CYP1A2CYP2C19CYP2C9NPC1RAB9A | |
| SCHEMBL3098898 | 0.75 | CYP1A2 (0.37) | CYP1A2LMNACYP3A4MAOAADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5585090-A | MIXTURE OF METAL OXIDE FLAKE AND ULTRAVIOLET ABSORBENTENCAPSULATED POLYMER | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-17 | — | — | US | claimed |
| EP-0503922-B1 | Cosmetics having photoprotection properties | MAX FACTOR KK (JP) | 1995-12-20 | — | — | EP | claimed |
| EP-0503922-A2 | Cosmetics having photoprotection properties | MAX FACTOR K.K. (JP) | 1992-09-16 | — | — | EP | claimed |
| US-12414977-B2 | Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250268972-A1 | 5a-REDUCTASE INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| US-20240189215-A1 | FILM-FORMING COMPOSITION | KAO CORPORATION (JP) | 2024-06-13 | — | — | US | disclosed |
| EP-3763353-B1 | METHOD FOR IMPROVING WATER SOLUBILITY OF SPARINGLY-SOLUBLE COMPONENT | ADEKA CORP (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-20240009091-A1 | OIL-IN-WATER-TYPE COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2024-01-11 | — | — | US | disclosed |
| EP-4286015-A1 | OIL-IN-WATER-TYPE EMULSION COSMETIC | Kao Corporation (JP) | 2023-12-06 | — | — | EP | disclosed |
| EP-4252862-A1 | FILM-FORMING COMPOSITION | Kao Corporation (JP) | 2023-10-04 | — | — | EP | disclosed |
| US-20230190854-A1 | METHOD OF REDUCING MUSCLE DAMAGE ASSOCIATED WITH INTENSIVE EXERCISE BY ADMINISTERING PURPLE-TEA EXTRACT | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| WO-2006137576-A1 | COSMETICS COMPRISING A MODIFIED ORGANOPOLYSILOXANE | DOW CORNING TORAY CO., LTD. (JP) | 2006-12-28 | — | — | WO | disclosed |
| EP-1674106-A1 | DIETETIC COMPOSITION | Oryza Oil & Fat Chemical Co., Ltd (JP) | 2006-06-28 | — | — | EP | disclosed |
| US-20060100177-A1 | Stabilized ascorbic acid derivatives | SHOWA DENKO K.K. (JP) | 2006-05-11 | — | — | US | disclosed |
| EP-1496889-B1 | STABILIZED ASCORBIC ACID DERIVATIVES | SHOWA DENKO KK (JP) | 2005-08-17 | — | — | EP | disclosed |
| EP-1496889-A1 | STABILIZED ASCORBIC ACID DERIVATIVES | Showa Denko K.K. (JP) | 2005-01-19 | — | — | EP | disclosed |
| WO-2003086384-A1 | STABILIZED ASCORBIC ACID DERIVATIVES | SHOWA DENKO K. K. (JP) | 2003-10-23 | — | — | WO | disclosed |
| US-5585090-A | MIXTURE OF METAL OXIDE FLAKE AND ULTRAVIOLET ABSORBENTENCAPSULATED POLYMER | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0503922-B1 | Cosmetics having photoprotection properties | MAX FACTOR KK (JP) | 1995-12-20 | — | — | EP | disclosed |
| EP-0503922-A2 | Cosmetics having photoprotection properties | MAX FACTOR K.K. (JP) | 1992-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100177-A1 | Stabilized ascorbic acid derivatives | RBP1, SOD1, PROC | CYP1A2 365/4885LMNA 1389/4885CYP3A4 1546/4885 |
| US-20230190854-A1 | METHOD OF REDUCING MUSCLE DAMAGE ASSOCIATED WITH INTENSIVE EXERCISE BY ADMINISTERING PURPLE-TEA EXTRACT | PYGM, MUSK, GCK | CYP1A2 2761/4885LMNA 2182/4885CYP3A4 1790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.